A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant gain of 95.11% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 79.05%. Over the past 30 days, the price of QNTM has leaped by -32.58%. And in the last five days, it has surged by 63.18%.
The market performance of Quantum BioPharma Ltd has been somewhat unstable. Over the past year, the company’s stock achieved a high of $48.96 on 03/19/24, with the lowest value for the same timeframe being $2.70, recorded on 12/20/24.
52-week price history of QNTM Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Quantum BioPharma Ltd’s current trading price is -85.34% away from its 52-week high, while its distance from the 52-week low is 165.93%. The stock’s price range for this period has been between $2.70 and $48.96. The Healthcare sector company’s shares saw a trading volume of about 8.39 million for the day, which was higher than the average daily volume of 2.45 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Quantum BioPharma Ltd (QNTM) has experienced a quarterly rise of 68.54% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 13.79M.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.11, with a change in price of -0.37. Similarly, Quantum BioPharma Ltd recorded 1,587,905 in trading volume during the last 100 days, posting a change of -4.90%.
QNTM’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for QNTM stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.00.
QNTM Stock Stochastic Average
As of today, the raw stochastic average of Quantum BioPharma Ltd over the last 50 days is at 28.39%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 52.68%. Further, the company’s Stochastic %K and %D values for the last 20 days were 23.73% and 12.55%, respectively.
